The pharmacokinetics services market is anticipated to grow significantly, reaching a value of US$ 985.3 million by 2031, up from US$ 712 million in 2023. This growth represents a compound annual growth rate (CAGR) of 4.3% from 2023 to 2031.
Market Drivers for Pharmacokinetics Services
Increasing Incidence of Chronic and Infectious Diseases
The rise in chronic conditions such as diabetes, cancer, and autoimmune disorders is a major factor driving drug development globally. According to the World Health Organization (WHO) data from 2024, approximately 422 million individuals worldwide are affected by diabetes, predominantly in low- and middle-income nations, leading to around 1.5 million fatalities annually. Pharmaceutical companies are actively engaged in creating medications to combat these diseases. Pharmacokinetic studies play a crucial role in understanding the behavior of these drugs within the human body by examining the processes of absorption, distribution, metabolism, and excretion (ADME).
The absorption phase determines how quickly and effectively a drug enters systemic circulation, influencing its concentration at the site of action, such as plasma. The distribution of a drug throughout the body is influenced by its chemical properties and the physiological characteristics of the body. Metabolism refers to how the body processes the drug into various compounds, which is vital for converting drugs into forms that can be easily eliminated, such as water-soluble substances for renal clearance. This phase is also essential for transforming prodrugs, like codeine, into their active forms. Excretion primarily occurs through the kidneys, but can also happen via the lungs, skin, or gastrointestinal tract. The dynamics of ADME are critical in determining the bioavailability of drugs, and the maintenance doses are calculated based on their clearance rates, which are derived from the desired plasma concentration divided by bioavailability. A thorough understanding of clearance rates enables healthcare professionals to establish appropriate dosing regimens.
Pharmacokinetic studies are vital for optimizing drug dosing schedules in clinical subjects, ensuring the efficacy and safety of medications. These studies are particularly important for long-term treatment drugs, as they help assess the stability and suitability of drug formulations for managing chronic diseases. Consequently, the increasing burden of chronic and infectious diseases emphasizes the necessity of pharmacokinetic studies in developing safe and effective personalized therapies.
Opportunities in the Pharmacokinetics Services Market
The management and analysis of extensive pharmacokinetic data generated during drug development can be both costly and labor-intensive. This complexity underscores the need for advanced models, such as pharmacokinetic simulation models and in vitro-in vivo pharmacokinetic correlation (IVIVC) models, to predict pharmacokinetic parameters effectively. The pharmacokinetic simulation model utilizes computational and mathematical techniques to interpret drug kinetics under specific conditions in a living organism. Additionally, IVIVC models are integral to the drug discovery process, allowing for early-stage analysis of pharmacokinetic and pharmacodynamic (PK/PD) predictions, which are essential for optimizing lead compounds and minimizing attrition rates in drug development.
Recent advancements in in vitro and in vivo methodologies have enhanced the characterization of pharmacokinetic properties. IVIVC models are emerging as a cost-effective solution for evaluating the biopharmaceutical characteristics of drugs, including their bioavailability and practical applications. Therefore, these innovative in vivo and in vitro models are expected to create significant opportunities for growth in the pharmacokinetics services market in the coming years.
Segmental Analysis of the Pharmacokinetics Services Market
The market is categorized by drug type into small molecules, large molecules, and vaccines, with the small molecule segment commanding the largest market share in 2023.
In terms of therapeutic applications, the pharmacokinetics services market is divided into oncology, infectious diseases, neurological disorders, autoimmune diseases, gynecological disorders, cardiovascular diseases, respiratory disorders, and others. The oncology segment also held the largest market share in 2023.
Geographical Insights into the Pharmacokinetics Services Market
North America is the leading region in the pharmacokinetics services market. A report from the Government of Canada indicates that Health Canada receives numerous clinical trial applications aimed at testing new drugs, including vaccines, or exploring new uses for existing medications. Pediatric patients in Canada can participate in clinical trials with parental consent, and Health Canada ensures the protection of all trial participants, including minors. The Canadian Clinical Trials Asset Map (CCTAM) reported approximately 3,500 clinical trials registered in Canada in 2022, with cancer therapeutics being a significant focus, accounting for 1,300 cancer-related trials in 2021. The pharmaceutical sector invested around US$ 1.2 billion in clinical research in Canada, as noted in the Innovative Medicines Canada report. Furthermore, the Canadian Clinical Trials Network (CCTN) maintained over 6 million patient records as of 2021. Thus, the increasing demand for pharmacokinetic services is driven by the growing number of drug development and discovery projects in Canada, alongside the rising incidence of chronic and infectious diseases, which are key factors contributing to the expansion of the pharmacokinetics services market in the region.
TABLE OF CONTENTS
1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Pharmacokinetics Services Market Landscape
4.1 PEST Analysis
5. Pharmacokinetics Services Market - Key Market Dynamics
5.1 Pharmacokinetics Services Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Chronic and Infectious Diseases
5.2.2 Expanding Range of Application of Pharmacokinetic Studies
5.2.3 Outsourcing of Pharmacokinetics Services to CROs
5.3 Market Restraints
5.3.1 Limited Reach of Pharmacokinetics Service Providers in Emerging Countries
5.4 Market Opportunities
5.4.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics
5.5 Future Trend
5.5.1 Increasing Adoption of Big Data Analytics in Pharmacokinetics Services
5.6 Impact of Drivers and Restraints:
6. Pharmacokinetics Services Market - Global Market Analysis
6.1 Pharmacokinetics Services Market Revenue (US$ Million), 2023-2031
7. Pharmacokinetics Services Market Analysis - by Drug Type
7.1 Overview
7.2 Small Molecule
7.2.1 Overview
7.2.2 Small Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Large Molecule
7.3.1 Overview
7.3.2 Large Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Vaccines
7.4.1 Overview
7.4.2 Vaccines: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8. Pharmacokinetics Services Market Analysis - by Service Type
8.1 Pre-Clinical ADME and Human Studies
8.1.1 Overview
8.1.2 Pre-Clinical ADME and Human Studies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.2 PK/PD Analysis and Reporting
8.2.1 Overview
8.2.2 PK/PD Analysis and Reporting: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Dosing Simulations
8.3.1 Overview
8.3.2 Dosing Simulations: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Risk Analysis
8.4.1 Overview
8.4.2 Risk Analysis: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9. Pharmacokinetics Services Market Analysis - by Therapeutic Application
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Infectious Diseases
9.2.1 Overview
9.2.2 Infectious Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Neurological Disorders
9.3.1 Overview
9.3.2 Neurological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Autoimmune Diseases
9.4.1 Overview
9.4.2 Autoimmune Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Gynecological Disorders
9.5.1 Overview
9.5.2 Gynecological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Cardiovascular Diseases
9.6.1 Overview
9.6.2 Cardiovascular Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Respiratory Disorders
9.7.1 Overview
9.7.2 Respiratory Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10. Pharmacokinetics Services Market Analysis - by End User
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Contract Research Organization
10.2.1 Overview
10.2.2 Contract Research Organization: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11. Pharmacokinetics Services Market - Geographical Analysis
11.1 North America
11.1.1 North America Pharmacokinetics Services Market Overview
11.1.2 North America: Pharmacokinetics Services Market - Revenue and Forecast Analysis - by Country
11.1.2.1 United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.1.1 Overview
11.1.2.1.2 United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.1.3 United States: Pharmacokinetics Services Market Breakdown, by Drug Type
11.1.2.1.4 United States: Pharmacokinetics Services Market Breakdown, by Service Type
11.1.2.1.5 United States: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.1.2.1.6 United States: Pharmacokinetics Services Market Breakdown, by End User
11.1.2.2 Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.2.1 Overview
11.1.2.2.2 Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.2.3 Canada: Pharmacokinetics Services Market Breakdown, by Drug Type
11.1.2.2.4 Canada: Pharmacokinetics Services Market Breakdown, by Service Type
11.1.2.2.5 Canada: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.1.2.2.6 Canada: Pharmacokinetics Services Market Breakdown, by End User
11.1.2.3 Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.3.1 Overview
11.1.2.3.2 Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.3.3 Mexico: Pharmacokinetics Services Market Breakdown, by Drug Type
11.1.2.3.4 Mexico: Pharmacokinetics Services Market Breakdown, by Service Type
11.1.2.3.5 Mexico: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.1.2.3.6 Mexico: Pharmacokinetics Services Market Breakdown, by End User
11.2 Europe
11.2.1 Europe Pharmacokinetics Services Market Overview
11.2.2 Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3 Pharmacokinetics Services Market Breakdown by Countries
11.2.4 Pharmacokinetics Services Market Revenue and Forecast and Analysis - by Country
11.2.4.1 Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.1.1 Overview
11.2.4.1.2 Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.1.3 Germany: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.1.4 Germany: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.1.5 Germany: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.2.4.1.6 Germany: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.2 France: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.2.1 Overview
11.2.4.2.2 France: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.2.3 France: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.2.4 France: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.2.5 France: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
The market for infectious diseases segment is estimated to be worth US$ 19.24 million by 2031 and is expected to register a CAGR of 10.8% during the 2023-2031.
11.2.4.2.6 France: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.3 United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.3.1 Overview
11.2.4.3.2 United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.3.3 United Kingdom: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.3.4 United Kingdom: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.3.5 United Kingdom: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.2.4.3.6 United Kingdom: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.4 Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.4.1 Overview
11.2.4.4.2 Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.4.3 Italy: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.4.4 Italy: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.4.5 Italy: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.2.4.4.6 Italy: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.5 Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.5.1 Overview
11.2.4.5.2 Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.5.3 Spain: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.5.4 Spain: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.5.5 Spain: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.2.4.5.6 Spain: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.6 Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.6.1 Overview
11.2.4.6.2 Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.6.3 Rest of Europe: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.6.4 Rest of Europe: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.6.5 Rest of Europe: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.2.4.6.6 Rest of Europe: Pharmacokinetics Services Market Breakdown, by End User
11.3 Asia Pacific
11.3.1 Asia Pacific Pharmacokinetics Services Market Overview
11.3.2 Asia Pacific: Pharmacokinetics Services Market
11.3.3 Asia Pacific: Pharmacokinetics Services Market - Revenue and Forecast Analysis - by Country
11.3.3.1 China: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.1.1 Overview
11.3.3.1.2 China: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.1.3 China: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.1.4 China: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.1.5 China: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.1.6 China: Pharmacokinetics Services Market Breakdown, by End User
11.3.3.2 Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.2.1 Overview
11.3.3.2.2 Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.2.3 Japan: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.2.4 Japan: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.2.5 Japan: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.2.6 Japan: Pharmacokinetics Services Market Breakdown, by End User
11.3.3.3 India: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.3.1 Overview
11.3.3.3.2 India: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.3.3 India: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.3.4 India: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.3.5 India: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.3.6 India: Pharmacokinetics Services Market Breakdown, by End User
11.3.3.4 Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.4.1 Overview
11.3.3.4.2 Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.4.3 Australia: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.4.4 Australia: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.4.5 Australia: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.4.6 Australia: Pharmacokinetics Services Market Breakdown, by End User
11.3.3.5 South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.5.1 Overview
11.3.3.5.2 South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.5.3 South Korea: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.5.4 South Korea: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.5.5 South Korea: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.5.6 South Korea: Pharmacokinetics Services Market Breakdown, by End User
11.3.3.6 Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.6.1 Overview
11.3.3.6.2 Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.6.3 Rest of APAC: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.6.4 Rest of APAC: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.6.5 Rest of APAC: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.6.6 Rest of APAC: Pharmacokinetics Services Market Breakdown, by End User
11.4 Middle East and Africa
11.4.1 Middle East and Africa Pharmacokinetics Services Market Overview
11.4.2 Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3 Pharmacokinetics Services Market Breakdown by Countries
11.4.4 Pharmacokinetics Services Market Revenue and Forecast and Analysis - by Country
11.4.5 Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast Analysis - by Country
11.4.5.1 Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.1.1 Overview
11.4.5.1.2 Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.1.3 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by Drug Type
11.4.5.1.4 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by Service Type
11.4.5.1.5 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.4.5.1.6 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by End User
11.4.5.2 South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.2.1 Overview
11.4.5.2.2 South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.2.3 South Africa: Pharmacokinetics Services Market Breakdown, by Drug Type
11.4.5.2.4 South Africa: Pharmacokinetics Services Market Breakdown, by Service Type
11.4.5.2.5 South Africa: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.4.5.2.6 South Africa: Pharmacokinetics Services Market Breakdown, by End User
11.4.5.3 United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.3.1 Overview
11.4.5.3.2 United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.3.3 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by Drug Type
11.4.5.3.4 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by Service Type
11.4.5.3.5 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.4.5.3.6 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by End User
11.4.5.4 Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.4.1 Overview
11.4.5.4.2 Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.4.3 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Drug Type
11.4.5.4.4 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Service Type
11.4.5.4.5 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.4.5.4.6 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by End User
11.5 South and Central America
11.5.1 South and Central America Pharmacokinetics Services Market Overview
11.5.2 South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.3 Pharmacokinetics Services Market Breakdown by Countries
11.5.4 Pharmacokinetics Services Market Revenue and Forecast and Analysis - by Country
11.5.4.1 Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.1.1 Overview
11.5.4.1.2 Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.1.3 Brazil: Pharmacokinetics Services Market Breakdown, by Drug Type
11.5.4.1.4 Brazil: Pharmacokinetics Services Market Breakdown, by Service Type
11.5.4.1.5 Brazil: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.5.4.1.6 Brazil: Pharmacokinetics Services Market Breakdown, by End User
11.5.4.2 Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.2.1 Overview
11.5.4.2.2 Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.2.3 Argentina: Pharmacokinetics Services Market Breakdown, by Drug Type
11.5.4.2.4 Argentina: Pharmacokinetics Services Market Breakdown, by Service Type
11.5.4.2.5 Argentina: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.5.4.2.6 Argentina: Pharmacokinetics Services Market Breakdown, by End User
11.5.4.3 Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.3.1 Overview
11.5.4.3.2 Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.3.3 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by Drug Type
11.5.4.3.4 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by Service Type
11.5.4.3.5 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.5.4.3.6 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by End User
12. Company Profile
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Eurofins Scientific SE
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Certara Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.5 Parexel International Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Allucent
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PACIFIC BIOLABS
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 SGS SA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Shanghai Medicilon Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About
LIST OF TABLES
Table 1. Pharmacokinetics Services Market Segmentation
Table 2. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 3. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 4. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 5. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 6. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 7. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 8. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 9. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 10. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 11. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 12. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 13. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 14. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 15. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 16. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 17. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 18. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 19. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 20. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 21. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 22. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 23. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 24. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 25. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 26. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 27. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 28. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 29. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 30. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 31. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 32. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 33. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 34. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 35. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 36. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 37. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 38. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 39. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 40. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 41. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 42. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 43. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 44. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 45. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 46. R&D Expenditure of Indian Companies, 2018-2020 (US$ Million)
Table 47. Company
Table 48. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 49. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 50. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 51. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 52. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 53. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 54. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 55. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 56. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 57. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 58. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 59. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 60. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 61. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 62. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 63. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 64. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 65. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 66. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 67. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 68. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 69. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 70. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 71. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 72. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 73. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 74. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 75. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 76. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 77. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 78. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 79. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 80. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 81. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 82. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 83. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 84. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 85. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 86. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 87. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 88. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 89. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 90. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 91. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
LIST OF FIGURES
Figure 1. Pharmacokinetics Services Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Pharmacokinetics Services Market Revenue (US$ Million), 2023-2031
Figure 5. Pharmacokinetics Services Market, By Geography Forecast Analysis, 2023 & 2031
Figure 6. Pharmacokinetics Services Market Share (%) - by Drug Type (2023 and 2031)
Figure 7. Small Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Large Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Vaccines: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Pharmacokinetics Services Market Share (%) - by Service Type (2023 and 2031)
Figure 11. Pre-Clinical ADME and Human Studies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. PK/PD Analysis and Reporting: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Dosing Simulations: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Risk Analysis: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Pharmacokinetics Services Market Share (%) - by Therapeutic Application (2023 and 2031)
Figure 17. Oncology: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Infectious Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Neurological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Autoimmune Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Gynecological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Cardiovascular Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (
The List of Companies - Pharmacokinetics Services Market?
Charles River Laboratories International Inc.
Eurofins Scientific SE
Evotec SE
Certara Inc.
Parexel International Corp
Thermo Fisher Scientific Inc.
Allucent
PACIFIC BIOLABS
SGS SA
Shanghai Medicilon Inc.
